UTMD Launches $48.75M Self-Tender at $75/Share — 20.5% of Shares Outstanding
UTMD sits 40% above its 52-week low of $53.66.
Summary
UTMD is tendering for 650,000 shares (20.5% of outstanding) at $75 each, a $48.75M capital return. Insiders are not selling, and the CEO says the stock is worth $90.
Key Events · Financing and Capital Events · UTMD
-
Self-Tender for 20.5% of Shares
UTMD offers to buy 650,000 shares at $75.00 each, a 6% premium to the $70.67 closing price on September 14, 2026. Total cost approximately $49 million including expenses.
-
Pro Forma Equity Impact
If fully subscribed, stockholders' equity drops from $122 million to $73 million, and book value per share falls from $38.34 to $28.82. EPS increases from $0.84 to $0.93 for Q2 2026 on a pro forma basis.
-
Insiders Not Tenderings
Directors and executive officers (7 persons) own 7.6% of shares and have advised they do not intend to tender any shares. Their ownership would rise to 9.5% post-offer.
-
CEO Valuation Commentary
Chairman & CEO Kevin Cornwell states UTMD shares are undervalued at $75 and would fairly trade around $90 per share using industry and S&P 500 valuation multiples.
Analysis · UTMD · Industrial Applications And Services
Utah Medical Products is buying back 20.5% of its outstanding shares at $75 each, a 6% premium to the $70.67 closing price before announcement. The $48.75 million capital return will slash stockholders' equity from $122 million to $73 million and boost EPS by roughly 10% on a pro forma basis. Insiders — who own 7.6% of the company — are not tendering, which concentrates their ownership to 9.5% post-offer. CEO Kevin Cornwell explicitly states the stock is undervalued at $75 and worth $90 based on industry multiples. This is a major vote of confidence from management, but it comes against a backdrop of declining revenue (down 14% in Q2) and lost customers.
How filings like this one have moved
In the 30 days to Nov 1, 2026, 39.9% of the 1106 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.34%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, UTMD was trading at $75.00 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $238.8M. The 52-week trading range was $53.66 to $76.89. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.